Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Hannah Taylor

Dr Hannah Taylor

Hannah Taylor


Medical Statistician

Hannah obtained her BSc in Physiology at the University of Liverpool in 2010, and later completed an MSc in Biomechanics at the University of Manchester in 2012. After a spell as a secondary science teacher, she undertook a PhD in cardiovascular epidemiology at UCL in 2016, examining associations between adiposity and cardiac structural and functional outcomes in adolescents. While writing up her thesis, she worked as a post-doc at UCL and looked at health outcomes in schoolteachers, and the associations between adiposity and psychosocial wellbeing in adolescents. 

In 2020 she began working as a statistical epidemiologist at NDPH and spent time investigating associations between adiposity and cardiovascular risk, in both UK-based and international cohorts. She then worked as a medical statistician in the Early Breast Cancer Trialists' Collaborative Group, in which she helped to analyse data from randomised clinical trials of breast cancer treatment. 

Currently Hannah works as an epidemiologist in the UK Biobank team and helps to review applications for access to the dataset, alongside continuing her research into risk factors for cardiovascular disease. 

Hannah is involved with the Early Career Research networks within NDPH and the British and Irish Hypertension Society (BIHS), and in 2019 she won the Young Investigator Oral Prize at the BIHS Annual Scientific Meeting. She is especially interested in the relationship between lifestyle behaviours, body composition and blood-based biomarkers and the risk of cardiovascular disease and cancer, and the respective roles which age, gender and ethnicity play in modifying these associations.